Factors influencing the development of leprosy: An overview

International Journal of Leprosy and Other Mycobacterial Diseases

Volumn 69, Issue 1, 2001, Pages 26-33

  Naafs, B ^a   Silva, E ^a   Vilani Moreno, F ^a   Marcos, E C ^a   Nogueira, M E ^a   Opromolla, D V A ^a  

^a NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; HLA ANTIGEN;

CLINICAL FEATURE; CYTOKINE RELEASE; DELAYED HYPERSENSITIVITY; DISEASE COURSE; DISEASE TRANSMISSION; HEREDITY; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; INSECT BITE; LEPROSY; MYCOBACTERIUM LEPRAE; REVIEW; SEXUAL TRANSMISSION; SKIN MANIFESTATION;

HUMANS; LEPROSY; MYCOBACTERIUM LEPRAE;

EID: 0034923670     PISSN: 0148916X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (100)

1. Salivary immunoglobulins and antibody activities in leprosy
2. Epidemiological significance of first skin lesion in leprosy
3. Granulomatous reaction to intradermal injection of lepromin is linked to the human NRAMP1 gene in Vietnamese siblings
4. Transmission of viable Mycobacterium leprae by Aedes aegypti from lepromatous leprosy patients to the skin of mice through interrupted feeding
5. A clinical study of the nose in leprosy
6. Nature and familial character of the lepromin reactions
7. The genetics of resistance to leprosy
8. Lepromin reaction: Genetic studies including twin pair analysis
9. A reação de Mitsuda oitenta anos depois
10. The Nramp1 protein and its role in resistance to infection and macrophage function
11. Imunogenetica
12. Estudo de associaço entre antigenos HLA e reacço hansenica tipo 1 ulcerada
13. The influence of nerves on the secretion of immunoglobulin A into submandibular saliva in rats
14. Histopathology of the nasal mucosa in leprosy
15. Association of recurrent vaginal candidiasis and secretory ABO and Lewis phenotype
16. A twin study on leprosy
17. Transmission of leprosy in nude mice
18. Mucosal immunity to mycobacteria in leprosy patients and their contacts
19. Leprosy transmission and mucosal immunity: Towards eradication?
20. HLA segregation of tuberculoid leprosy: Conformation of the DR2 marker
21. HLA-linked control of predisposition to lepromatous leprosy
22. The genetic epidemiology of leprosy in a Brazilian population
23. Leprosy: The epidemiology of a slow bacterium
24. Delayed-type hypersensitivity, mycobacterial vaccines and protective immunity
25. Report of workshop on epidemiology/transmission/vaccines
26. The effect of heterologous immunity upon the apparent efficacy of (e.g. BCG) vaccines
27. The nose in leprosy; immunohistopatholology of the nasal mucosa
28. The fly as a potential vector in the transmission of leprosy
29. Quantitative estimation of Mycobacterium leprae in exhaled nasal breath
30. Gamma delta T cells as mediators of mucosal tolerance: The autoimmune diabetes model
31. Spedalskhedens aarsager
32. Leprosy in the United States
33. The distribution of the first lesion in leprosy
34. An epidemiological study on Mycobacterium leprae infection and prevalence of leprosy in endemic villages by molecular biological technique
35. Transmission of leprosy in nude mice through thom pricks
36. Histopathologic evidence to show that indeterminate leprosy may be a primary lesion of the disease
37. "Large numbers" of Mycobacterium leprae are discharged from the intact skin of lepromatous patients; a preliminary report
38. Lewis blood group-related antigen expression in normal gastric mucosa, intestinal metaplasia, gastric adenoma and gastric carcinoma
39. Isolation of environment-derived Mycobacterium leprae from soil in Bombay
40. Detection of mycobacterial carriage in a leprosy endemic population
41. Inherited variability of tumor necrosis factor production and susceptibility to infectious disease
42. Influence of dose and route of antigen injection in the immunological induction of T-cells
43. Sensitisation to mycobacteria in two areas of Zimbabwe with different distribution of leprosy clinical type and leprosy incidence: ELISA
44. Classification of leprosy
45. On the mode of transmission of Mycobacterium leprae
46. Understanding of the genetic basis of susceptibility to mycobacterial infection
47. Protective efficacy of BCG against leprosy in Sao Paulo
48. Influence of environmental mycobacteria on the prevalence of leprosy clinical type
49. Mycobacterium leprae DNA in daily using water as a possible source of leprosy infection
50. Mode of transmission and histology of M. leprae infection in nude mice
51. Leprosy
52. Tuberculoid leprosy and HLA in Japanese
53. Sensitisation to mycobacteria in two areas in Zimbabwe with different distribution of leprosy type and leprosy incidence: Skin tests
54. Comparison of the modes of spread and the age of onset of leprosy and tuberculosis
55. Leprosy: General introduction
56. Eziopatogenesi
57. Current views on reactions in leprosy
58. Transfer of leprosy bacilli from patients to mouse foot pads by Aedes aegypti
59. Classificacao
60. Association of HLA specificity LB-E12 (MB1, DC1, MT1) with lepromatous leprosy in a Venezuelan population
61. How might Mycobacterium leprae enter the body
62. The presence of M. leprae in human milk
63. Composite skin contact smears: A method of demonstrating the non-emergence of Mycobacterium leprae from intact lepromatous skin
64. Two simultaneous cases of leprosy developing in tattoos
65. Transmission and protection in leprosy; indications of the role of mucosal immunity
66. Comparison of the modes of spread and the incidence of tuberculosis and leprosy
67. Airborne infection with Mycobacterium leprae in mice
68. Classification of leprosy according to immunity; a five-group system
69. Protective effect of intradermal BCG against leprosy; a case-control study in central Brazil
70. Contagiousness of leprosy
71. Some aspects of immunity in leprosy and their importance in epidemiology, pathogenesis and classification of forms of the disease
72. Fiftieth anniversary of the "N-factor/Hansen-anergic fringe" hypothesis for hanseniasis
73. Tumor necrosis factor promotor polymorphism and susceptibility to lepromatous leprosy
74. Decreased cellular and humoral anti-infective factors in the breast secretions of lactating mothers with lepromatous leprosy
75. Association of the Lewis-blood phenotype with recurrent urinary tract infections in women
76. Sensitisation or tolerance to Mycobacterium leprae antigens by route of injection
77. Mechanisms of nasal tolerance induction in experimental autoimmune myasthenia gravis; identification of regulatory cells
78. Sistema sanguineo Lewis em patientes hansenianos
79. Infecção espontânea e experimental de hematofagos em leprosos
80. Da lepra; sua provavel transmissio pelos artropodos
81. Leprosy and arthropods
82. Natural resistance to mycobacteria: Antimicrobial activity and reactive oxygen intermediate releasing functions of murine macrophages
83. How environmental mycobacteria may predetermine the protective influence of BCG
84. In-vitro lymphoproliferative response to Mycobacterium leprae of HLA-D-identical siblings of lepromatous leprosy patients
85. Importance of the neural predilection of Mycobacterium leprae in leprosy
86. Histological studies in primairy neuritic leprosy: Changes in the nasal mucosa
87. Nasal administration of glutamate decarboxylase (GAD65) peptides induces Th2 responses and prevents murine insulin-dependant diabetes
88. Intranasal exposure to protein antigens induces immunological tolerance mediated by functionally disabled CD4+ T cells
89. Epidemiologia
90. Hanseniase experimental murina: Inoculação do Mycobacterium leprae via intranasal
91. HLA-linked genetic control of host response to Mycobacterium leprae
92. HLA-linked control of susceptibility to tuberculoid leprosy and association with HLA-DR types